Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹1Accepted-AOC | ₹1 | L1 | Accepted-AOC L1 |
| 2 | L1₹1Accepted-AOC TULIP BLOCK GITANJALI DR REGO BAGH ALTO SANTACRUZ BAMBOLIM GOA 403202 | NORTH GOA | GOA | 403202 | ₹1 | L1 | Accepted-AOC L1 |
Tender Value
Refer Docs
EMD Value
₹1 L
Closing Date
4 Apr 2024, 12:00 pmClosed
THE DY. DIRECTOR OF HEALTH SERVICES (E AND S)
Central Medical Stores 141, A J C Bose Road, Kolkata - 700014
RE E TENDER FOR PROCUREMENT OF SOME KITS FOR TWO YEARS FROM THE DATE OF AWARD OF CONTRACT (AOC)
2024_HFW_680661_1
WBHF/CMS/HST/4T-78-2023 /KITS-RT(248)/2024/283
Open Tender
Equipments
Item Wise
730 days
KOLKATA
Please refer Tender documents.
3 documents required · 3 mandatory
₹1 L
Yes
4 Oct 2024
6 Mar 2024
4 Apr 2024
6 Mar 2024
4 Apr 2024
15 Mar 2024
Rh +K phenotyping glass bead cassettes Technical Specification: 1.Cassttes should contain 6 columns filled with glass bead as filtration media 2.1st Column to 5th column should be prefilled with monoclonal antisera such as Anti C, Anti E, Anti c, Anti e, Anti K respectively and 6th column is 'control' column. 3.PEG should be present in the columns as enhancer to increase uptake of antibody 4. Assay time should be as per manufacturer's guideline / brochure 5. Mixed field reaction /double cell population should be detected
AHG poly specific glass bead cassettes Technical Specification: 1. Cassettes should contain 6 columns filled with glass beads filtration media 2. All column should prefilled with AHG reagent (Anti IgG , Anti C3d) 3. Assay time should be as per manufacturer's guideline / brochure 4. Mixed filled reaction /double cell population should be detected
Blood Grouping (Forward & reverse grouping) glass bead cassettes Technical Specification: 1. Cassettes should contain 6 columns filled with glass bead as filtration media 2. 1st to 3rd Colums should be prefilled with monoclonal antisera with a serial of Anti A, Anti B, Anti D respectively and rest 3 colums contain 1 for 'control' and 2 colums for reverse grouping with variable serial. 3. PEG should be present in the columns as enhancer to increase uptake of antibody 4. Centrifugation time should be as per manufacturer's guideline 5. Mixed field reaction /double cell population should be detected
Monoclonal Antisera for extended Rh+K phenotyping Anti C Technical Specification: Anti C sera should be monoclonal Anti C sera should be compatible for conventional test tube method The potency titre of the antisera should not be less than 4.
Monoclonal Antisera for extended Rh+K phenotyping Anti c Technical Specification: Anti c sera should be monoclonal Anti c sera should be compatible for conventional test tube method The potency titre of the antisera should not be less than 4.
Monoclonal Antisera for extended Rh+K phenotyping Anti E Technical Specification: Anti E sera should be monoclonal Anti E sera should be compatible for conventional test tube method The potency titre of the antisera should not be less than 4.
Monoclonal Antisera for extended Rh+K phenotyping Anti e Technical Specification: Anti e sera should be monoclonal Anti e sera should be compatible for conventional test tube method The potency titre of the antisera should not be less than 4.
Monoclonal Antisera for extended Rh+K phenotyping Anti K (Kell) Technical Specification: Anti K sera should be monoclonal Anti K sera should be compatible for conventional test tube method The potency titre of the antisera should not be less than 4.
Panel for Antibody 3 cell Screening applicable to Conventional Test Tube method and Glass Bead Cassettes Technical Specification: 1. Cell Panel should be 2%-5% of RBC suspended in saline 2. Cell Panel should be compatible with both conventional test tube method and glass bead cassettes of column agglutination technology for doing antibody screening test 3. Cell panel should contain RBC with the antigens of extended Rh, Kell, Duffy, Kidd, Lewis, MNS etc blood group system 4. Dose depended antigens (like MNS, Duffy etc) should be present in homozygous as per criteria of antibody screening test 5. Cell panel should be compatible for enzyme treatment 6. Pack size should be as per manufacturer's guideline / brochure
Panel for Antibody 3 cell Screening applicable to gel card Technical Specification: 1.Cell Panel should be 0.8%-1% of RBC suspended in Low ionic strength saline 2. Cell Panel should be compatible with gel card of column agglutination technology for doing antibody screening test 3. Cell panel should contain RBC with the antigens of extended Rh, Kell, Duffy, Kidd, Lewis, MNS etc blood group system 4.Dose depended antigens (like MNS, Duffy etc) should be present in homozygous as per criteria of antibody screening test 5. Cell panel should be compatible for enzyme treatment 6. Pack size should be as per manufacturer's guideline / brochure
Panel for Antibody 11 cell Identification Test applicable to Conventional Test Tube method and Glass Bead Cassettes Technical Specification: 1. Cell Panel should be 2%-5% of RBC suspended in saline 2. Cell Panel should be compatible with both conventional test tube method and glass bead cassettes of column agglutination technology for doing antibody identification test 3. Cell panel should contain RBC with the antigens of extended Rh, Kell, Duffy, Kidd, Lewis, MNS etc blood group system 4. Dose depended antigens (like MNS, Duffy etc) should be present in homozygous as per criteria of antibody identification test 5. Cell panel should contain RBC with the one or more heterozygous expression of dose dependent antigens (MNS,Duffy) for better interpretation of result. 6. Cell panel should be compatible for enzyme treatment 7. Pack size should be as per manufacturer's guideline / brochure
Panel for Antibody 11 cell Screening applicable to gel card Technical Specification: 1. Cell Panel should be 0.8%-1% of RBC suspended in Low ionic strength saline 2. Cell Panel should be compatible with gel card of column agglutination technology for doing antibody screening test 3.Cell panel should contain RBC with the antigens of extended Rh, Kell, Duffy, Kidd, Lewis, MNS etc blood group system 4. Dose depended antigens (like MNS, Duffy etc) should be present in homozygous as per criteria of antibody identification test 5. Cell panel should contain RBC with the one or more heterozygous expression of dose dependent antigens (MNS, Duffy) for better interpretation of result. 6. Cell panel should be compatible with enzyme treatment 7. Pack size should be as per manufacturer's guideline / brochure
Low ionic Strength Saline for Glass bead cassettes Low ionic strength saline should be compatible for glass bead cassettes for doing antibody screening , antibody identification or any other IAT test. Pack size should be as per manufacturer's guideline / brochure
Note : - 1. Physical Demonstration of performance of Testing kit(s) :Technically qualified bidders have to undergo Physical Demonstration of performance of Testing kit(s) by the Experts before being eligible as finally qualified for financial bid opening .The specific date & time of the same will be notified later on. 2. The participating bidders of the Gel Card (Cat No. R06(b)/KCR & B15(b)/KCR) are requested to bid for the respective diluents also. If not participated in both Gel Card & diluents then the technical bid of the bidder will not be evaluated and will be rejected. 3. L1 bidder of the Gel card, must accept the L1 rate of the diluents, if not achieved L1 status in the diluents. Otherwise, the L1 bidder of the Diluents will be offered to accept the L1 rate of the Gel Card. 4. Where Rate per ml is invited, after finalization of the tender minimum pack size will be accepted. 5. Quality of the product supplied / to be supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period. 6. The Items should be US FDA/CE/ ICMR/NIB/CDSCO approved (US FDA/ CE certificate will be applicable only when the Indian Standards like ICMR/NIB/CDSCO is not available). 7. In case of imported items NABL/NIB/NIV/CDL or equivalent authorized Lab accredited by Parent country will be considered. 8. If every supplied batch of the approved vendor contains test report from NIB/NIV/NARI/ICMR then the 2% testing charge will not be deducted from the bill(s).
Ortho Clinical Diagnostics IPL
M16(b)/KCR
M16(c)/KCR
M16(d)/KCR
P23(b)/KCR
P24(b)/KCR
Ortho Clinical Diagnostics IPL
B15(a)/KCR
M16(e)/KCR
P23(a)/KCR
P24(a)/KCR
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .